Creso Pharma Limited (ASX: CPH) has expanded into the Canadian market with the proposed acquisition of emerging Nova Scotia-based medicinal cannabis producer, Mernova Medicinal Inc (Mernova) for a total of C$10.1 million (A$10.2 million) in cash and equity. Creso has an established footprint in Canada’s recreational market via its wholly-owned subsidiary Mernova Medicinal Inc. STOCK CHART Investor Highlights News A Look Inside Creso Canada Creso Pharma Limited’s (ASX:CPH) Nova Scotia-based, 24,000 sq ft purpose-built, “state of the art” indoor cannabis growing facility. • Acquisition of Mernova Medicinal Inc (Mernova) for C$10.1 million (A$10.2 million) in cash and equity. • Creso Pharma (ASX:CPH) becomes the only Australian cannabis company with direct exposure to the world’s largest legal Creso Pharma Ltd’s (OTCMKTS:COPHF) (FRA:1X8) wholly-owned Canadian subsidiary, Mernova Medicinal Inc has made a strategic decision to expand its current operations and target the Canadian hash market. The Canadian subsidiary of Creso Pharma (ASX: CPH), Mernova Medicinal Inc, has been awarded the trade mark by the Ontario Cannabis Store (OCS) for its Ritual Green cannabis products. Creso Pharma Ltd’s (FRA:1X8) wholly-owned Canadian subsidiary, Mernova Medicinal Inc has secured three new purchase orders with total value of C$177,122.40 (A$183,019.551), including a first purchase order for Mernova’s Pre-roll Joint range sold under the Ritual Sticks brand. advise that it’s wholly-owned Canadian subsidiary Mernova Medicinal Inc. (“Mernova”), has secured four purchase orders (“PO”) for its leading Ritual Green product range, with a total value of C$494,131 (A$502,1991). Mernova Medicinal Inc. is a Nova Scotia company seeking to become a Licensed Producer issued by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR). Mernova Medicinal Inc is scaling up cannabis production towards maximum capacity to meet growing demand from medical and recreational markets in Canada. Creso Pharma Limited’s (ASX:CPH; FRA:1X8) wholly-owned subsidiary, Mernova Medicinal Inc. (Mernova), a Licensed Producer of cannabis products with its operations based in Nova Scotia, Canada, has received an initial purchase order (PO) valued at C$180,000. Creso Pharma Limited (ASX:CPH, FRA:1X8) has announced three new purchase orders for its wholly-owned Canadian subsidiary, Mernova Medicinal Inc, with a total value of C$177,122.40 (A$183,019.55). Feedback from end-users and resellers is that initial orders will occur immediately upon Mernova’s launch into hash. Creso Pharma Limited ( ASX:CPH , FRA:1X8) has announced that its wholly owned Canadian subsidiary, Mernova Medicinal Inc, has won new purchase orders (POs) from Ontario Cannabis Store (OCS) and … View Charles Williams’ profile on LinkedIn, the world’s largest professional community. Mernova has also introduced a new product segment, the one-ounce bag, so that customers can get a larger supply of its leading cannabis strains. Creso Pharma’s Mernova Medical Inc. facility in Nova Scotia, Canada Mernova production ramps up, significant deal closed In the meantime, Mernova is continuing to ramp up production and sales in North America, with its latest In Nova Scotia, where Creso Pharma’s wholly-owned subsidiary Mernova Medicinal Inc. is located, cannabis companies are fortunate to have a cooperative partner in the Nova Scotia Liquor Corporation, which is the sole distributor Mernova Medicinal Inc. is a Licensed Cultivation Producer under the Canadian Cannabis Act. Creso Pharma (ASX: CPH) utilises pharmaceutical expertise and methodological rigour to develop cannabis and hemp derived therapeutic, nutraceutical and lifestyle products with wide range patient and consumer reach for human and animal health. BRIEF-Creso Pharma Ltd offers to acquire Mernova Medicinal for C$10.1 mln July 27 (Reuters) - Creso Pharma Ltd CPH.AX * Creso Pharma Ltd says proposed acquisition of Mernova Medicinal Inc for a total C$10.1 million What’s more, Mernova expects to add additional orders to include its new “Black Mamba” artisanal craft strain – an Indica dominant strain with more than 20 per cent THC. Share Price: $0.075 Market capitalisation: $14.5 million Here’s why I like Creso Pharma: Creso’s Canopy connection Creso Pharma Limited has appointed two executives to the senior management team of its wholly-owned Mernova Medical Inc. in Nova Scotia, Canada. Mernova Medicinal Inc. Share Price and News. Key points: • Acquisition of Mernova Medicinal Inc (Mernova) for C$10.1 million (A$10.2 million) in cash and equity. Creso is also building momentum on the other side of the globe, with its wholly owned subsidiary, Mernova Medicinal Inc., last week receiving its second order for recreational cannabis from the Nova Scotia Liquor Corporation Creso Pharma Limited (ASX:CPH, FRA:1X8) (‘Creso Pharma’ or ‘the Company’) is pleased to advise its wholly-owned Canadian subsidiary, Mernova Medicinal Inc. (“Mernova”) has secured four new purchase orders (“PO”) with a(A$ The founder and CEO is William (Bill) Fleming. Ritual Green is a small batch manufacturer based in Nova Scotia with approximately 30 employees who care for every plant and bud to deliver the premium quality … Mernova, a licensed producer in Nova Scotia, Canada, subsidiary of Creso Pharma Limited’s. Mernova Medicinal is licensed by Health Canada and operates a cannabis cultivation, extraction and production facility in Nova Scotia. July 27 (Reuters) - Creso Pharma Ltd () Creso Pharma Ltd says proposed acquisition of Mernova Medicinal Inc for a total C$10.1 million “To support the launch and increase brand awareness, Mernova has initiated a number of branding and sales campaigns, including on social media, in coordination with high-profile Canadian … Owned by Creso Pharma Ltd., an international cannabis and hemp company - acquired in 2019 Owned by Creso Pharma Ltd., an international cannabis and hemp company – acquired in … With the GMP-based facility being completed in Q3 2018 . Mernova Medicinal Inc.(Mernova) is a privately held company based in Halifax, Nova Scotia, Canada. Mernova has Creso’s wholly owned Canadian subsidiary Mernova Medicinal Inc. secures four new purchase orders (POs) totalling C$494,131 (A$502,1991) Cannabis News On Feb 18, 2021 About Mernova Medicinal Inc. Mernova Medicinal is licensed by Health Canada and operates a cannabis cultivation, extraction and production facility in Nova Scotia. InPlanta Biotechnology Inc. 4401 University Dr W, Lethbridge, AB T1K 6T5 | distance: 11,626 Kilometers (705) 717-2210 InPlanta Biotechnology Inc. is Canada’s first authorized licensed nursery under the Cannabis Act. See the complete profile on LinkedIn and discover Charles’ connections and jobs at similar companies. Both companies have previously navigated through complex regulatory frameworks to launch 10 recreational cannabis products under the Ritual Green and Ritual Sticks brands in four Canadian provinces. Charles has 4 jobs listed on their profile. Find the latest MediciNova, Inc. (MNOV) stock quote, history, news and other vital information to help you with your stock trading and investing. Dual-listed developer of cannabis and hemp-derived products, Creso Pharma Limited (ASX:CPH, FRA:1X8), announced that its Canadian subsidiary, Mernova Medicinal Inc, had won three new purchase orders (PO) with a total value of A$183K. Today on the Daily Dive, we sit down with Jack Yu, managing director of Mernova Medicinal, Creso Pharma's (ASX: CPH) Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions.